Key Insights

Highlights

Success Rate

79% trial completion

Published Results

35 trials with published results (15%)

Research Maturity

77 completed trials (33% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

8.7%

20 terminated out of 230 trials

Success Rate

79.4%

-7.2% vs benchmark

Late-Stage Pipeline

5%

12 trials in Phase 3/4

Results Transparency

45%

35 of 77 completed with results

Key Signals

35 with results79% success20 terminated

Data Visualizations

Phase Distribution

167Total
Not Applicable (66)
Early P 1 (6)
P 1 (52)
P 2 (31)
P 3 (8)
P 4 (4)

Trial Status

Completed77
Recruiting66
Unknown28
Terminated20
Active Not Recruiting14
Withdrawn10

Trial Success Rate

79.4%

Benchmark: 86.5%

Based on 77 completed trials

Clinical Trials (230)

Showing 20 of 20 trials
NCT07203534Not ApplicableRecruitingPrimary

ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period

NCT04690205Not ApplicableCompletedPrimary

Hospital at Home at EOL in Heme Malignancies

NCT07710781Not ApplicableNot Yet RecruitingPrimary

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

NCT07257419Phase 1Recruiting

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

NCT06415656Not ApplicableCompletedPrimary

VitalTraq for the Detection of CRS

NCT05400122Phase 1Suspended

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

NCT06532773Not ApplicableRecruitingPrimary

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

NCT06989489Not ApplicableRecruiting

Implementation of an Oral Chemotherapy Adherence Intervention

NCT06960993Not ApplicableRecruitingPrimary

Mosaic Trial for Stem Cell Transplant Recipients

NCT05397132CompletedPrimary

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

NCT07006506Phase 2Recruiting

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

NCT07672964Phase 1Not Yet RecruitingPrimary

CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation

NCT07300735Not ApplicableRecruitingPrimary

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

NCT07662369Phase 1RecruitingPrimary

CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation

NCT02134574RecruitingPrimary

Prospective Cohort With Hemopathy in Languedoc-Roussillon

NCT06579469Recruiting

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

NCT07133074Phase 4Recruiting

Allergy Delabeling in Antibiotic Stewardship - Intervention

NCT03890614Active Not RecruitingPrimary

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

NCT05384288RecruitingPrimary

Response to Influenza Vaccination in Pediatric Oncology Patients

NCT06401356Phase 3RecruitingPrimary

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Scroll to load more

Research Network

Activity Timeline